An­oth­er four biotechs make Wall Street de­but, rais­ing $772M+ as IPO tidal wave crests

As four more biotechs go pub­lic Fri­day morn­ing, the ques­tion must be asked — if a glob­al pan­dem­ic can’t stop an IPO boom, can any­thing?

The tsuna­mi con­tin­ues with iTeos, Nurix, An­nex­on and In­ozyme all mak­ing their trad­ing de­buts as the week comes to a close. iTeos and Nurix both priced at $19 per share, with each rais­ing $201.1 mil­lion and $209 mil­lion, re­spec­tive­ly. An­nex­on priced at $17 per share and raised $250.8 mil­lion, while In­ozyme priced at $16 per share and raised $112 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.